ETFIQData as of Nov 18, 2026. · etfiq.com/funds/qsml

QSML Fact Sheet: WisdomTree U.S. SmallCap Quality Growth Fund

Share
$34.20
close, Nov 18, 2026

Over the year to Nov 18, 2026, QSML returned +26.8% in total and charged 0.38% a year.

1-year total return
+26.8%
IWV +12.0% to Nov 18, 2026
Expense ratio
0.38%
a year
Net flow, 12 months to Jun 30, 2026
+$666k
monthly N-PORT basis to Jun 30, 2026

Growth of $10,000, 1 year

QSML $12,682 +26.8% · IWV $11,199 +12.0% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+2.9%
3 months−2.5%
Year to date+18.8%
1 year+26.8%
Since launch+38.4%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
ACM RESEARCH INC0.78%
TG THERAPEUTICS INC0.77%
ACUSHNET HOLDINGS CORP0.69%
HIMS & HERS HEALTH INC0.69%
PTC THERAPEUTICS INC0.67%
VSE CORP0.65%
INSTALLED BUILDING PRODUCTS INC0.63%
ESSENT GROUP LTD0.63%
ESAB CORP0.62%
LIGAND PHARMACEUTICALS INC0.61%

QSML top ten by weight, 6.8% of the fund, of its 376 equity positions, from the holdings filed for Jun 30, 2026.

Facts

Equity fund · Tracks the WisdomTree U.S. SmallCap Quality Growth Index · First traded Jan 25, 2024 · Benchmark Russell 3000 Index, measured by IWV, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, QSML Fact Sheet: WisdomTree U.S. SmallCap Quality Growth Fund. Data as of Nov 18, 2026. https://etfiq.com/funds/qsml/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/qsml.